Stay updated on XZP-5955 Tablets in NTRK/ROS1+ Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the XZP-5955 Tablets in NTRK/ROS1+ Solid Tumors Clinical Trial page.

Latest updates to the XZP-5955 Tablets in NTRK/ROS1+ Solid Tumors Clinical Trial page
- CheckyesterdayChange DetectedThe history now shows a new revision entry v3.4.3. The previous revision v3.4.2 has been removed.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check30 days agoChange DetectedRevision: v3.4.2 was added; the notice about government funding lapses and the older Revision: v3.4.1 were removed from the history.SummaryDifference0.9%

- Check37 days agoChange DetectedA site-wide notice about a lapse in government funding and operating status was added. The record history now shows a new version entry, Revision: v3.4.1, and the previous entry v3.4.0 was removed.SummaryDifference0.9%

- Check44 days agoChange DetectedThe history view now shows a glossary toggle, highlights additions in green and deletions in red, and displays revision notes such as Revision: v3.4.0, with No FEAR Act data reference removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

- Check58 days agoChange DetectedA new revision entry v3.3.4 was added to the record history, and the previous revision v3.3.3 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check79 days agoChange DetectedThe page now shows a new 'Revision: v3.3.3' label and the 'HHS Vulnerability Disclosure' link has been removed (and 'Revision: v3.3.2' is no longer listed). These are minor administrative updates to the page footer and revision history.SummaryDifference0.2%

Stay in the know with updates to XZP-5955 Tablets in NTRK/ROS1+ Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XZP-5955 Tablets in NTRK/ROS1+ Solid Tumors Clinical Trial page.